ropinirole hydrochloride
ropinirole hydrochloride is listed in the FDA National Drug Code directory with 32 NDC codes, marketed under brand names including ROPINIROLE HYDROCHLORIDE, ropinirole hydrochloride. Available dosage forms: tablet, film coated, extended release, tablet, film coated.
Drug details
- Generic Name
- ropinirole hydrochloride
- Brand Names
- ROPINIROLE HYDROCHLORIDE, ropinirole hydrochloride
- Application Number
- ANDA090869
- Sponsor
- AvKARE
- NDC Codes
- 32
- Dosage Forms
- TABLET, FILM COATED, EXTENDED RELEASE, TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- ROPINIROLE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Ropinirole tablets are a non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS). ( 1.1 , 1.2 ) 1.1 Parkinson’s Disease Ropinirole tablets are indicated for the treatment of Parkinson's disease. 1.2 Restless Legs Syndrome Ropinirole tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).